Vireo Growth (VREOF) Acquisitions (2025 - 2026)

Vireo Growth (VREOF) reported Acquisitions of -$18.2 million for Q1 2026, down 207.15% sequentially from -$5.9 million in Q4 2025.

Vireo Growth (VREOF) Acquisitions (2025 - 2026) Analysis & Trends

Vireo Growth (VREOF) has 2 years of Acquisitions data on file, last reported at -$18.2 million in Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Acquisitions (Qtr)
1	Haleon	87.22 Bn	85.35 Bn	-	-
2	Teva Pharmaceutical Industries	39.60 Bn	35.87 Bn	1.97 Bn	-
3	Zoetis	31.46 Bn	29.52 Bn	1.62 Bn	-
4	Takeda Pharmaceutical	26.49 Bn	22.44 Bn	4.39 Bn	-
5	United Therapeutics	23.03 Bn	20.88 Bn	648.10 Mn	-
6	Universe Pharmaceuticals	23.03 Bn	-10.56 Bn	-	-
7	Viatris	20.90 Bn	19.09 Bn	1.16 Bn	-
8	Neurocrine Biosciences	17.50 Bn	16.19 Bn	800.70 Mn	-
9	Elanco Animal Health	12.33 Bn	11.91 Bn	785.00 Mn	-
10	Vireo Growth	10.57 Bn	10.41 Bn	59.30 Mn	-18.20 Mn

Download Data